PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response.

MLA

Tang, Oliver Y., et al. “PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response.” Frontiers in Immunology, vol. 13, May 2022, p. 872756. EBSCOhost, https://doi.org/10.3389/fimmu.2022.872756.

APA

Tang, O. Y., Tian, L., Yoder, T., Xu, R., Kulikovskaya, I., Gupta, M., Melenhorst, J. J., Lacey, S. F., O’Rourke, D. M., & Binder, Z. A. (2022). PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response. Frontiers in Immunology, 13, 872756. https://doi.org/10.3389/fimmu.2022.872756

Chicago

Tang, Oliver Y, Lifeng Tian, Todd Yoder, Rong Xu, Irina Kulikovskaya, Minnal Gupta, Jan Joseph Melenhorst, Simon F Lacey, Donald M O’Rourke, and Zev A Binder. 2022. “PD1 Expression in EGFRvIII-Directed CAR T Cell Infusion Product for Glioblastoma Is Associated with Clinical Response.” Frontiers in Immunology 13 (May): 872756. doi:10.3389/fimmu.2022.872756.